Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
Oxidative stress, which is associated with metabolic and anthropometric perturbations, leads to reactive oxygen species production and decrease in plasma adiponectin concentration. We investigated pharmacodynamically the pathophysiological role and potential implication of exogenously administered a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2021/6661181 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562336382058496 |
|---|---|
| author | Sheryar Afzal Munavvar Abdul Sattar Edward James Johns Olorunfemi A. Eseyin Ali Attiq |
| author_facet | Sheryar Afzal Munavvar Abdul Sattar Edward James Johns Olorunfemi A. Eseyin Ali Attiq |
| author_sort | Sheryar Afzal |
| collection | DOAJ |
| description | Oxidative stress, which is associated with metabolic and anthropometric perturbations, leads to reactive oxygen species production and decrease in plasma adiponectin concentration. We investigated pharmacodynamically the pathophysiological role and potential implication of exogenously administered adiponectin with full and partial peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists on modulation of oxidative stress, metabolic dysregulation, and antioxidant potential in streptozotocin-induced spontaneously hypertensive rats (SHR). Group I (WKY) serves as the normotensive control, whereas 42 male SHRs were randomized equally into 7 groups (n=6); group II serves as the SHR control, group III serves as the SHR diabetic control, and groups IV, V, and VI are treated with irbesartan (30 mg/kg), pioglitazone (10 mg/kg), and adiponectin (2.5 μg/kg), whereas groups VII and VIII received cotreatments as irbesartan+adiponectin and pioglitazone+adiponectin, respectively. Diabetes was induced using an intraperitoneal injection of streptozotocin (40 mg/kg). Plasma adiponectin, lipid contents, and arterial stiffness with oxidative stress biomarkers were measured using an in vitro and in vivo analysis. Diabetic SHRs exhibited hyperglycemia, hypertriglyceridemia, hypercholesterolemia, and increased arterial stiffness with reduced plasma adiponectin and antioxidant enzymatic levels (P<0.05). Diabetic SHRs pretreated with pioglitazone and adiponectin separately exerted improvements in antioxidant enzyme activities, abrogated arterial stiffness, and offset the increased production of reactive oxygen species and dyslipidemic effects of STZ, whereas the blood pressure values were significantly reduced in the irbesartan-treated groups (all P<0.05). The combined treatment of exogenously administered adiponectin with full PPAR-γ agonist augmented the improvement in lipid contents and adiponectin concentration and restored arterial stiffness with antioxidant potential effects, indicating the degree of synergism between adiponectin and full PPAR-γ agonists (pioglitazone). |
| format | Article |
| id | doaj-art-bbf28096308d494a9ed02c4c9f01f084 |
| institution | Kabale University |
| issn | 1687-4765 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | PPAR Research |
| spelling | doaj-art-bbf28096308d494a9ed02c4c9f01f0842025-02-03T01:22:56ZengWileyPPAR Research1687-47652021-01-01202110.1155/2021/66611816661181Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive RatsSheryar Afzal0Munavvar Abdul Sattar1Edward James Johns2Olorunfemi A. Eseyin3Ali Attiq4Department of Pharmacology & ToxicologyDepartment of Pharmacology & ToxicologySchool of Pharmaceutical SciencesSchool of Pharmaceutical SciencesDepartment of Pharmacology & ToxicologyOxidative stress, which is associated with metabolic and anthropometric perturbations, leads to reactive oxygen species production and decrease in plasma adiponectin concentration. We investigated pharmacodynamically the pathophysiological role and potential implication of exogenously administered adiponectin with full and partial peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists on modulation of oxidative stress, metabolic dysregulation, and antioxidant potential in streptozotocin-induced spontaneously hypertensive rats (SHR). Group I (WKY) serves as the normotensive control, whereas 42 male SHRs were randomized equally into 7 groups (n=6); group II serves as the SHR control, group III serves as the SHR diabetic control, and groups IV, V, and VI are treated with irbesartan (30 mg/kg), pioglitazone (10 mg/kg), and adiponectin (2.5 μg/kg), whereas groups VII and VIII received cotreatments as irbesartan+adiponectin and pioglitazone+adiponectin, respectively. Diabetes was induced using an intraperitoneal injection of streptozotocin (40 mg/kg). Plasma adiponectin, lipid contents, and arterial stiffness with oxidative stress biomarkers were measured using an in vitro and in vivo analysis. Diabetic SHRs exhibited hyperglycemia, hypertriglyceridemia, hypercholesterolemia, and increased arterial stiffness with reduced plasma adiponectin and antioxidant enzymatic levels (P<0.05). Diabetic SHRs pretreated with pioglitazone and adiponectin separately exerted improvements in antioxidant enzyme activities, abrogated arterial stiffness, and offset the increased production of reactive oxygen species and dyslipidemic effects of STZ, whereas the blood pressure values were significantly reduced in the irbesartan-treated groups (all P<0.05). The combined treatment of exogenously administered adiponectin with full PPAR-γ agonist augmented the improvement in lipid contents and adiponectin concentration and restored arterial stiffness with antioxidant potential effects, indicating the degree of synergism between adiponectin and full PPAR-γ agonists (pioglitazone).http://dx.doi.org/10.1155/2021/6661181 |
| spellingShingle | Sheryar Afzal Munavvar Abdul Sattar Edward James Johns Olorunfemi A. Eseyin Ali Attiq Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats PPAR Research |
| title | Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats |
| title_full | Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats |
| title_fullStr | Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats |
| title_full_unstemmed | Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats |
| title_short | Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats |
| title_sort | antioxidant potential of adiponectin and full ppar γ agonist in correcting streptozotocin induced vascular abnormality in spontaneously hypertensive rats |
| url | http://dx.doi.org/10.1155/2021/6661181 |
| work_keys_str_mv | AT sheryarafzal antioxidantpotentialofadiponectinandfullppargagonistincorrectingstreptozotocininducedvascularabnormalityinspontaneouslyhypertensiverats AT munavvarabdulsattar antioxidantpotentialofadiponectinandfullppargagonistincorrectingstreptozotocininducedvascularabnormalityinspontaneouslyhypertensiverats AT edwardjamesjohns antioxidantpotentialofadiponectinandfullppargagonistincorrectingstreptozotocininducedvascularabnormalityinspontaneouslyhypertensiverats AT olorunfemiaeseyin antioxidantpotentialofadiponectinandfullppargagonistincorrectingstreptozotocininducedvascularabnormalityinspontaneouslyhypertensiverats AT aliattiq antioxidantpotentialofadiponectinandfullppargagonistincorrectingstreptozotocininducedvascularabnormalityinspontaneouslyhypertensiverats |